CDKL5 and epilepsy: RND provided information in a cohort of 32 patients harboring a mutation in CDKL5. Expectedly, for the early seizure variant of RTT caused by CDKL5 mutations, the majority of patients experienced at least one episode of epilepsy (>90% in all three cohorts).